APA (7th ed.) Citation

Čižnár, P., Roderick, M., Schneiderova, H., Jeseňák, M., Kriván, G., Brodszki, N., . . . Yel, L. (2024). fSCIG 10% in pediatric primary immunodeficiency diseases: A European post-authorization safety study. Allergy, Asthma & Clinical Immunology, 20(1), 1. https://doi.org/10.1186/s13223-024-00904-9

Chicago Style (17th ed.) Citation

Čižnár, Peter, et al. "FSCIG 10% in Pediatric Primary Immunodeficiency Diseases: A European Post-authorization Safety Study." Allergy, Asthma & Clinical Immunology 20, no. 1 (2024): 1. https://doi.org/10.1186/s13223-024-00904-9.

MLA (9th ed.) Citation

Čižnár, Peter, et al. "FSCIG 10% in Pediatric Primary Immunodeficiency Diseases: A European Post-authorization Safety Study." Allergy, Asthma & Clinical Immunology, vol. 20, no. 1, 2024, p. 1, https://doi.org/10.1186/s13223-024-00904-9.